The role of hypnotherapy for the treatment of inflammatory bowel diseases

References

• Fuller-Thomson E, Sulman J. Depression and inflammatory. bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006;12:697-707
   PubMed Web of Science ®Google Scholar
• Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008;103(8):1989-97
   PubMed Web of Science ®Google Scholar
• Koschke M, Boettger MK, Schulz S, et al. Autonomy of autonomic dysfunction in major depression. Psychosom Med 2009;71(8):852-60
   PubMed Web of Science ®Google Scholar
• Bitton A, Sewitch MJ, Peppercorn MA, et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol 2003;98:2203-8
   PubMed Web of Science ®Google Scholar
• Bitton A, Dobkin PL, Edwardes MD, et al. Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut 2008;57(10):1386-92
   PubMed Web of Science ®Google Scholar
• Duffy LC, Zielezny MA, Marshall JR, et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 1991;17:101-10
   PubMed Web of Science ®Google Scholar
• Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease – a prospective 18 months follow up study. Psychosom Med 2004;66:79-84
   PubMed Web of Science ®Google Scholar
• Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95:1213-20
   PubMed Web of Science ®Google Scholar
• Mawdsley J, Macey M, Feakins R, et al. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 2006;131:410-19
   PubMed Web of Science ®Google Scholar
• Maunder R, Greenberg G, Hunter J, et al. Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress. Am J Gastroenterol 2006;101:2546-51
   PubMed Web of Science ®Google Scholar
• Langhorst J, Hofstetter A, Wolfe F, Häuser W. Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study. Inflamm Bowel Dis 2013;19(11):2380-6
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010;105(9):1994-2002
   PubMed Web of Science ®Google Scholar
• Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013;144(1):36-49
   PubMed Web of Science ®Google Scholar
• Meregnani J, Clarençon D, Vivier M, et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 2011;160(1-2):82-9
   PubMed Web of Science ®Google Scholar
• Häuser W, Moser G, Klose P, Mikocka-Walus A. Are statements and recommendations on psychosocial issues included in evidence-based guidelines on the management of inflammatory bowel diseases? A systematic review. World J Gastroenterol 2014;20(13):3663-71
   PubMed Web of Science ®Google Scholar
• Goodhand JR, Wahed M, Rampton DS. Management of stress in inflammatory bowel disease: a therapeutic option? Expert Rev Gastroenterol Hepatol 2009;3(6):661-79
   PubMedGoogle Scholar
• Miehsler W, Weichselberger M, Offerlbauer-Ernst A, et al. Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease. Inflamm Bowel Dis 2004;10(5):637-45
   PubMed Web of Science ®Google Scholar
• Timmer A, Preiss JC, Motschall E, et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2011;16(2):CD006913
   Google Scholar
• McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis 2013;7(12):935-49
   PubMed Web of Science ®Google Scholar
• Knowles SR, Monshat K, Castle DJ. The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis 2013;19(12):2704-15
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4
   PubMed Web of Science ®Google Scholar
• Whorwell PJ. IBS: Hypnotherapy – a wasted resource? Nat Rev Gastroenterol Hepatol 2011;9(1):12-13
   PubMed Web of Science ®Google Scholar
• Palsson OS. Standardized hypnosis treatment for irritable bowel syndrome: the North Carolina protocol. Int J Clin Exp Hypn 2006;54:51-64
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987;28:423-5
   PubMed Web of Science ®Google Scholar
• Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-9
   PubMed Web of Science ®Google Scholar
• Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome – the effect of hypnotherapy. Aliment Pharmacol Ther 1996;10:91-5
   PubMed Web of Science ®Google Scholar
• Moser G, Trägner S, Gajowniczek EE, et al. Long-term success of gut-directed group hypnosis for patients with refractory irritable bowel syndrome- a randomized controlled trial. Am J Gastroenterol 2013;108(4):602-9
   PubMed Web of Science ®Google Scholar
• Schaefert R, Klose P, Moser G, Häuser W. Efficacy, tolerability and safety of hypnosis in adult irritable bowel syndrome - systematic review and meta-analysis. Psychosom Med 2014; In press
   PubMed Web of Science ®Google Scholar
• Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990;31:896-8
   PubMed Web of Science ®Google Scholar
• Lea R, Houghton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:635-42
   PubMed Web of Science ®Google Scholar
• Simrén M, Ringström G, Björnsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004;66(2):233-8
   PubMed Web of Science ®Google Scholar
• Francis CY, Houghton LA. Use of hypnotherapy in gastrointestinal disorders. Eur J Gastroenterol Hepatol 1996;8:525-9
   PubMed Web of Science ®Google Scholar
• Jones H, Cooper P, Miller V, et al. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut 2006;55:10-1403-8
   PubMed Web of Science ®Google Scholar
• Calvert EL, Houghton LA, Cooper P, et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002;123(6):1778-85
   PubMed Web of Science ®Google Scholar
• Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47:2605-14
   PubMed Web of Science ®Google Scholar
• Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology 1989;96(6):1383-7
   PubMed Web of Science ®Google Scholar
• Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004;56(3):271-8
   PubMed Web of Science ®Google Scholar
• Lowén MB, Mayer EA, Sjöberg M, et al. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 2013;37(12):1184-97
   PubMed Web of Science ®Google Scholar
• Lindfors P, Törnblom H, Sadik R, et al. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS). Scand J Gastroenterol 2012;47(12):1480-7
   PubMed Web of Science ®Google Scholar
• Vlieger AM, van den Berg MM, Menko-Frankenhuis C, et al. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2010;105(1):213-18
   PubMed Web of Science ®Google Scholar
• Mawdsley JE, Jenkins DG, Macey MG, et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 2008;103(6):1460-9
   PubMed Web of Science ®Google Scholar
• Peter JM, Tran US, Michalski M, Moser G. Irritable bowel syndrome and psychological comorbidity – long-term success of gut-directed group hypnosis. Psychother Psychosom 2013;82(suppl 1):84
   Google Scholar
• Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006;12(1):38-46
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7(11):1-33
   PubMed Web of Science ®Google Scholar
• Schäfer DW. Hypnosis and the treatment of ulcerative colitis and Crohn's disease. Am J Clin Hypn 1997;40(2):111-17
   PubMed Web of Science ®Google Scholar
• Keefer L, Keshavarzian A. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int J Clin Exp Hypn 2007;55(4):457-66
   PubMed Web of Science ®Google Scholar
• Miller V, Whorwell PJ. Treatment of inflammatory bowel disease: a role for hypnotherapy? Int J Clin Exp Hypn 2008;56(3):306-17
   PubMed Web of Science ®Google Scholar
• Emami MH, Gholamrezaei A, Daneshgar H. Hypnotherapy as an adjuvant for the management of inflammatory bowel disease: a case report. Am J Clin Hypn 2009;51(3):255-62
   PubMed Web of Science ®Google Scholar
• Keefer L, Taft TH, Kiebles JL, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 2013;38(7):761-71
   PubMed Web of Science ®Google Scholar
• Greifenegg M, Michalski M, Dejaco C, Moser G. Gut directed hypnosis for patients with inflammatory bowel diseases (IBD). Psychother Psychosom 2013;82(suppl 1):39
   Google Scholar
• Dür M, Sadlonova M, Haider S, et al. Health determining concepts important to people with Crohn’s disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis 2014;8:45-55
   PubMed Web of Science ®Google Scholar
• Hutfless SM, Weng X, Liu L, et al. Mortality by medication use among patients with inflammatory bowel disease, 1996–2003. Gastroenterology 2007;133:1779-86
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus AA, Andrews JA, Bernstein CN, et al. The integrated approach to managing inflammatory bowel disease (IBD): a discussion paper on various integrated models of care. Inflamm Bowel Dis 2012;18(8):1582-7
   PubMed Web of Science ®Google Scholar